RENDINA, LUCIANO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.925
EU - Europa 142
AS - Asia 63
SA - Sud America 6
Totale 2.136
Nazione #
US - Stati Uniti d'America 1.915
IE - Irlanda 29
CN - Cina 27
IT - Italia 26
KR - Corea 23
FR - Francia 17
GB - Regno Unito 16
UA - Ucraina 14
DE - Germania 13
CA - Canada 10
BE - Belgio 7
SE - Svezia 7
BR - Brasile 6
CZ - Repubblica Ceca 3
SG - Singapore 3
GR - Grecia 2
HK - Hong Kong 2
IN - India 2
JP - Giappone 2
LV - Lettonia 2
RU - Federazione Russa 2
AT - Austria 1
CH - Svizzera 1
FI - Finlandia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
VN - Vietnam 1
Totale 2.136
Città #
Houston 626
Wilmington 589
Woodbridge 186
Fairfield 88
Chandler 85
New York 38
Ashburn 36
Cambridge 36
Ann Arbor 31
Seattle 30
Dublin 29
Medford 20
Beijing 13
Seoul 12
Lawrence 10
Seongnam 9
Brussels 7
Dearborn 7
Rome 7
Creede 6
London 6
San Diego 6
Jacksonville 5
Irvine 4
San Francisco 4
Storm Lake 4
São Paulo 4
Boardman 3
Kunming 3
Prague 3
Toronto 3
Berlin 2
Bologna 2
Caserta 2
Chateaugiron 2
Elora 2
Hong Kong 2
Kyiv 2
Mcallen 2
Montreal 2
Norwalk 2
Ottawa 2
Palo Alto 2
Riga 2
Shanghai 2
Singapore 2
Zhengzhou 2
Almaty 1
Ariano Irpino 1
Arlington 1
Bratislava 1
Chiswick 1
Dong Ket 1
Eden Prairie 1
Frankfurt am Main 1
Guangzhou 1
Hefei 1
Jinan 1
Milan 1
Mülheim 1
Nanjing 1
Phoenix 1
Praia Grande 1
Prescot 1
Pune 1
Redmond 1
Redwood City 1
Saint Petersburg 1
San Jose 1
San Mateo 1
Santa Clara 1
Secaucus 1
Shenyang 1
Shenzhen 1
St. George 1
Thessaloníki 1
Tianjin 1
Tokyo 1
Trento 1
Trois-rivières 1
Turin 1
Vienna 1
Totale 1.977
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 435
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 340
Pathways to mental health care in Italy: Results from a multicenter study 299
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 241
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 224
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 208
Platelets and hepatocellular cancer: Bridging the bench to the clinics 143
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 96
Survival after the diagnosis of de novo malignancy in liver transplant recipients 82
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 64
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 18
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 17
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 12
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 11
Balancing donor and recipient risk factors in liver transplantation: The value of D-MELD with particular reference to HCV recipients 11
Totale 2.201
Categoria #
all - tutte 6.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019124 0 0 0 0 0 0 0 0 0 0 68 56
2019/2020755 61 48 33 65 54 64 77 58 77 96 59 63
2020/2021489 65 61 62 53 36 50 59 55 12 13 17 6
2021/2022124 15 12 9 5 4 8 10 3 13 13 7 25
2022/2023238 31 25 6 34 12 32 20 36 26 2 10 4
2023/2024103 11 7 8 5 15 42 4 0 3 6 2 0
Totale 2.201